DURECT Corp (DRRX) Reports In-Line Q4 EPS
Get Alerts DRRX Hot Sheet
Price: $1.91 --0%
Financial Fact:
Cost of product revenues: 2.18M
Today's EPS Names:
NRIX, VFS, GLDG, More
Financial Fact:
Cost of product revenues: 2.18M
Today's EPS Names:
NRIX, VFS, GLDG, More
Join SI Premium – FREE
DURECT Corp (NASDAQ: DRRX) reported Q4 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $3.52 million versus the consensus estimate of $3.61 million.
For earnings history and earnings-related data on DURECT Corp (DRRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Downgrades UWM Holdings Corp. (UWMC) to Neutral
- Lucid Group (LCID) Reiterated at Neutral by Cantor Fitzgerald as Bolt Targets Initial Fleet of ~25K Units
- Bristol Myers Squibb lung fibrosis drug meets Phase 3 trial goal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share